: Mallinckrodt stock soars, after disclosure that $200 million opioid-settlement payment was delayed by a week

Shares of Mallinckrodt PLC MNK shot up 26.5% in afternoon trading, after the drug maker said it reached an agreement to delay a $200 million opioid-settlement payment by a week. The stock’s rally comes after it closed Thursday below the $1 mark for the first time, at 87 cents. The opioid-settlement payment to the Opioid Master Disbursement Trust II, which was due June 16, pushed back to June 23. The company said it was “actively  evaluating the Company’s capital needs in light of its obligations under its opioid settlement and its long-term debt,” and was engaged in discussions with various stakeholders about its options, which potentially could include a bankruptcy filing. On Thursday, the company decided to not make interest payments on two senior-secured notes that were due that day. The stock has plunged 87.0% over the past three months, while the S&P 500 SPX has gained 11.8%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.